Survival Outcomes After Double-Lung Transplantation for Refractory Lung-Limited Cancers and Incidence of Post-Transplant Lung Cancer
Annals of Transplantation · 2023
DOI: 10.12659/aot.941301 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Transplantation, 2023. Verfasst von Jeeyeon Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. Hauptthemen laut MEDLINE: Lung Neoplasms, Lung Transplantation, Organ Transplantation. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
- School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Daegu, South Korea.
ORCID-Profile: Jeeyeon Lee, Maria Jose Aguilera Chuchuca, Jisang Yu, Liam Il-Young Chung, Ankit Bharat, Young Kwang Chae
Förderung
- NHLBI NIH HHS
Zitieren
APA
Lee, J., Aguilera Chuchuca, M. J., Yu, J., Chung, L. I., Bharat, A., & Chae, Y. K. (2023). Survival Outcomes After Double-Lung Transplantation for Refractory Lung-Limited Cancers and Incidence of Post-Transplant Lung Cancer. Annals of Transplantation. https://doi.org/10.12659/aot.941301
Vancouver
Lee J, Aguilera Chuchuca MJ, Yu J, Chung LI, Bharat A, Chae YK. Survival Outcomes After Double-Lung Transplantation for Refractory Lung-Limited Cancers and Incidence of Post-Transplant Lung Cancer. Annals of Transplantation. 2023. doi:10.12659/aot.941301
BibTeX
@article{Lee2023,
author = {Lee, Jeeyeon and Aguilera Chuchuca, Maria Jose and Yu, Jisang and Chung, Liam Il-Young and Bharat, Ankit and Chae, Young Kwang},
title = {Survival Outcomes After Double-Lung Transplantation for Refractory Lung-Limited Cancers and Incidence of Post-Transplant Lung Cancer},
journal = {Annals of Transplantation},
year = {2023},
doi = {10.12659/aot.941301}
}
EUVIMED